Page last updated: 2024-09-04

ezetimibe and sulfobromophthalein

ezetimibe has been researched along with sulfobromophthalein in 2 studies

Compound Research Comparison

Studies
(ezetimibe)
Trials
(ezetimibe)
Recent Studies (post-2010)
(ezetimibe)
Studies
(sulfobromophthalein)
Trials
(sulfobromophthalein)
Recent Studies (post-2010) (sulfobromophthalein)
2,4845631,4653,2093346

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fromm, MF; Giessmann, T; König, J; Kroemer, HK; Lütjohann, D; Oswald, S; Rimmbach, C; Rosskopf, D; Siegmund, W1
Duthaler, U; Krähenbühl, S; Malagnino, V; Meyer Zu Schwabedissen, HE; Seibert, I1

Trials

1 trial(s) available for ezetimibe and sulfobromophthalein

ArticleYear
Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1.
    Pharmacogenetics and genomics, 2008, Volume: 18, Issue:7

    Topics: Adult; Azetidines; Cells, Cultured; Ezetimibe; Female; Genotype; Humans; Inactivation, Metabolic; Liver; Liver-Specific Organic Anion Transporter 1; Male; Multidrug Resistance-Associated Protein 2; Organic Anion Transporters; Polymorphism, Single Nucleotide; Sterols; Sulfobromophthalein

2008

Other Studies

1 other study(ies) available for ezetimibe and sulfobromophthalein

ArticleYear
OATP1B3-1B7 (LST-3TM12) Is a Drug Transporter That Affects Endoplasmic Reticulum Access and the Metabolism of Ezetimibe.
    Molecular pharmacology, 2019, Volume: 96, Issue:2

    Topics: Biological Transport; Catalytic Domain; Endoplasmic Reticulum, Smooth; Ezetimibe; Glucuronosyltransferase; HeLa Cells; Humans; Intestine, Small; Microsomes, Liver; Organic Anion Transporters; Solute Carrier Proteins; Sulfobromophthalein

2019
chemdatabank.com